source
- Moderna begins early-stage trial of mRNA Ebola vaccineModerna announced the launch of an early-phase clinical trial testing an mRNA vaccine designed to protect against Ebola virus. The study will enroll healthy volunteers to evaluate the vaccine's saf…
- AstraZeneca and Bristol Myers Squibb abandon merger talksReuters reported that AstraZeneca and Bristol Myers Squibb have ended discussions about a possible merger and will not pursue a deal. The collapse of the talks removes a potential consolidation th…